April 25, 2010

By Dr. Unni Karunakara, incoming president of MSF's International Council, and Dr. Bernard Pecoul, executive director of the Drugs for Neglected Diseases initiative

January 20, 2010

By Dr. Rony Brauman, is the former President of MSF in France and is currently a Research Director at CRASH, MSF's center for reflection on humnaitarian action.

January 19, 2010

By Jeanne Cabeza,  MSF medical coordinator in Haiti, and Michelle Chouinard, MSF head of mission in Haiti

July 17, 2008

by Rony BRAUMAN Former president of MSF-France Associate Professor at the Institute of Political Studies in Paris

February 27, 2008

By Dr. Tido von Schoen-Angerer Executive director Access to Essential Medicines Campaign Doctors Without Borders

January 30, 2008

By Susan Shepherd The New York Times

August 15, 2007

The public sector has a key role in drug R&D. Patenting minor changes to extend monopoly prices spells misuse By Dr. Brian Druker

May 23, 2007

By Dr. Tido von Schoen-Angerer Executive director Access to Essential Medicines Campaign Doctors Without Borders

May 16, 2007

Dr. Buddhima Lokuge U.S. manager, Access to Essential Medicines Campaign

April 12, 2007

By David Wilson Medical Coordinator, Doctors Without Borders/Médecins Sans Frontieres

Pages